Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. | No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ...
Triple T, a new minimally invasive therapy, could replace adrenal surgery for treating primary aldosteronism, a hidden cause ...
Truck rim plate production begins with selecting high-quality MS sheets, which are cut into precise shapes using industrial-grade machinery. The sheets are then pressed and shaped to form sturdy rims.
We are entering a new era in the management of patients with multiple sclerosis (MS). The first oral treatment (fingolimod) has now gained US FDA approval, addressing an unmet need for patients ...
Work and Pensions Secretary Liz Kendall said there are ‘a lot of people’ claiming sickness or disability benefits who want to work (Joe Giddens/PA) PA Wire Ms Kendall told ITV: “I think what ...
Treatments including acupuncture, aromatherapy, reflexology and homeopathy can all help relieve the symptoms of MS. They can also help tackle the emotional problems associated with MS as patients ...
Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...
Potential treatments include heat therapy, acupuncture, or medications. There are many potential causes of back pain. Back pain may originate in the muscles, bones, or ligaments of the spine.
Heat sensitivity and the related worsening of MS symptoms are usually temporary ... is usually temporary and does not require specific treatment. However, cooling your body temperature, drinking ...
One potential use is treating MS symptoms. Botulinum neurotoxin therapy for MS leverages BoNT-A’s ability to block nerve signals to muscles. This temporary paralysis helps reduce excessive ...
The Phase III program CARE-MS, investigating alemtuzumab monotherapy in comparison to high-dose IFN therapy in treatment-naive RRMS patients (CARE-MS1) and in treatment-experienced patients with ...